| AMGEN INC. DL-,0001 |
| USA |
| Gesundheit |
| US0311621009 / 867900 |
| AMG (Frankfurt) / AMGN (NASDAQ) |
| FRA:AMG, ETR:AMG, AMG:GR, NASDAQ:AMGN |
| https://www.amgen.com/ |
|
Amgen Inc. is a global biotechnology company that discovers, develops, manufactures, and commercializes human therapeutics. Its current portfolio focuses on serious diseases across oncology, cardiovascular disease, inflammation, bone health, nephrolo..
>Volltext.. |
| 181532.6 Mio. EUR |
| 219431.45 Mio. EUR |
| 33261.79 Mio. EUR |
| 15142.9 Mio. EUR |
| 7612.37 Mio. EUR |
| 14.12 EUR |
| 49893.56 Mio. EUR |
| 12179.97 Mio. EUR |
| 10864.37 Mio. EUR |
| 0.55 |
| 13.35% |
| 36.25% |
| 8.51 EUR |
| 2.62% |
| 2.63% |
| 21.08.26 - 2.157876€ 15.05.26 - 2.1666958€ >weitere anzeigen... |
| - |
| AMGEN |
| 22.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|